Hot Features
Premium
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Zeitraum:
Zeichenmodus:
| Volumen | 349.770 |
|
|||||
| News | (1) | ||||||
| Tageshoch | 2,69 | Niedrig Hoch |
|||||
| Tagestief | 2,2301 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| NovaBay Pharmaceuticals Inc New | NBY | AMEX | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,07 | -2,72% | 2,50 | 01:59:02 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 2,50 | 2,2301 | 2,69 | 2,51 | 2,57 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 7.692 | 349.770 | US$ 2,46 | US$ 859.996 | - | 2,2301 - 44,80 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 02:00:00 | 288 | US$ 2,51 | USD |
Finanzwerte NBY
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 16,58M | 6,53M | - | 14,73M | -16,7M | -2,56 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News NovaBay Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 14.6.2024 | 14:47 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07.6.2024 | 13:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07.6.2024 | 12:50 | Business Wire | NovaBay Pharmaceuticals Plan of Compliance Accepted by the.. |
| 31.5.2024 | 22:50 | Edgar (US Regulatory) | Form 8-K - Current report |
| 31.5.2024 | 22:43 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 31.5.2024 | 03:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 31.5.2024 | 03:29 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 31.5.2024 | 03:27 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 31.5.2024 | 03:24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 31.5.2024 | 03:17 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 29.5.2024 | 23:27 | Edgar (US Regulatory) | Form 8-K - Current report |
| 29.5.2024 | 23:22 | Business Wire | NovaBay Pharmaceuticals Announces Approval of All Proposals.. |
Forum NovaBay Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
NBY Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 3,00 | 3,00 | 2,2301 | 2,69 | 81.159 | -0,50 | -16,67% |
| 1 Monat | 5,25 | 9,079 | 2,2301 | 5,12 | 22.191.931 | -2,75 | -52,38% |
| 3 Monate | 4,865 | 9,079 | 2,2301 | 4,72 | 9.769.748 | -2,37 | -48,61% |
| 6 Monate | 9,0685 | 10,15 | 2,2301 | 5,01 | 6.144.457 | -6,57 | -72,43% |
| 1 Jahr | 24,577 | 44,80 | 2,2301 | 6,76 | 3.378.542 | -22,08 | -89,83% |
| 3 Jahre | 903,56 | 1.074,57 | 2,2301 | 163,02 | 1.698.010 | -901,06 | -99,72% |
| 5 Jahre | 2.523,50 | 2.744,00 | 2,2301 | 750,60 | 2.069.631 | -2.521,00 | -99,90% |
